Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Linda Marban & Cantor Fitzgerald

2 shared events · Importance 3 · Last updated Sep 03, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
46
Regulatory
Linda Marban: CEO who made positive statements about Deramiocel; now named in securities fraud lawsuits.
Cantor Fitzgerald: Analyst firm that published a negative note on the FDA briefing documents.
Jul 27, 2026 · 305 articles
22
Regulatory
Linda Marban: Capricor's CEO, whose positive statements about HOPE-3 and Deramiocel are cited in the complaint as materially misleading.
Cantor Fitzgerald: Cantor Fitzgerald analyst Kristen Kluska published an investor note stating the FDA briefing documents paint an ugly picture and raise concerns about the integrity of data collection, a view cited in the complaint.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Linda Marban and Cantor Fitzgerald interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.